.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
QuintilesIMS
Farmers Insurance
McKinsey
Moodys
Argus Health
Accenture
Deloitte
US Department of Justice
Teva

Generated: July 24, 2017

DrugPatentWatch Database Preview

ONDANSETRON HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Ondansetron Hydrochloride, and what generic Ondansetron Hydrochloride alternatives are available?

Ondansetron Hydrochloride is a drug marketed by Chartwell Molecules, Apotex, Taro, Qilu Pharm Co Ltd, Pliva Hrvatska Doo, Lannett, Sandoz, Emcure Pharms, Gland Pharma Ltd, Sandoz Inc, Mylan, Glenmark Generics, Luitpold, Aurobindo Pharma, Hospira, Silarx, Hikma Intl Pharms, Accord Hlthcare, Sun Pharm Inds (in), Natco Pharma Ltd, Teva, Mylan Labs Ltd, West-ward Pharms Int, Ipca Labs Ltd, Apotex Inc, Fresenius Kabi Usa, Wockhardt, Sagent Pharms, Hikma Farmaceutica, Amneal Pharms, Dr Reddys Labs Ltd, Claris, Aurobindo Pharma Ltd, Taro Pharms Ireland, Emcure Pharms Ltd, and Sun Pharm Inds Ltd. and is included in sixty-seven NDAs.

The generic ingredient in ONDANSETRON HYDROCHLORIDE is ondansetron hydrochloride. There are twenty-eight drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. There are two tentative approvals for this compound. Additional details are available on the ondansetron hydrochloride profile page.

Summary for Tradename: ONDANSETRON HYDROCHLORIDE

Patents:0
Applicants:36
NDAs:67
Suppliers / Packagers: see list68
Bulk Api Vendors: see list49
Clinical Trials: see list2,588
Patent Applications: see list849
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ONDANSETRON HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: ONDANSETRON HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira
ONDANSETRON HYDROCHLORIDE AND DEXTROSE IN PLASTIC CONTAINER
ondansetron hydrochloride
INJECTABLE;INJECTION076978-001Feb 26, 2007DISCNNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds (in)
ONDANSETRON HYDROCHLORIDE
ondansetron hydrochloride
TABLET;ORAL077050-002Jun 25, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Hospira
ONDANSETRON HYDROCHLORIDE
ondansetron hydrochloride
INJECTABLE;INJECTION077840-001Jan 19, 2007APRXNoNo► Subscribe► Subscribe► Subscribe
Teva
ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE
ondansetron hydrochloride
INJECTABLE;INJECTION076759-001Nov 22, 2006APRXNoNo► Subscribe► Subscribe► Subscribe
Ipca Labs Ltd
ONDANSETRON HYDROCHLORIDE
ondansetron hydrochloride
TABLET;ORAL203761-001Jan 23, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
US Army
McKesson
Merck
Chubb
Baxter
Boehringer Ingelheim
McKinsey
Chinese Patent Office
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot